1,000+ Opportunities
Find the right grant
Search federal, foundation, and corporate grants with AI — or browse by agency, topic, and state.
This listing may be outdated. Verify details at the official source before applying.
Find similar grantsAtopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) is sponsored by National Institutes of Health (NIH). Supports centers integrating clinical and translational research to enhance understanding and management of atopic dermatitis, focusing on chronic skin inflammation and defense mechanisms.
Get a weekly digest of new grants like this
A free weekly digest of new foundation and federal funding opportunities as they're added to Granted. Unsubscribe anytime.
Or search similar grants →Extracted from the official opportunity page/RFP to help you evaluate fit faster.
Opportunity Listing - Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) Agency: National Institutes of Health Assistance Listings: 93. 855 -- Allergy and Infectious Diseases Research Last Updated: June 29, 2026 View version history on Grants.
gov The purpose of this notice of funding opportunity (NOFO) is to solicit applications for the Atopic Dermatitis Research Network (ADRN) program. The ADRN program will support Centers that integrate clinical and translational research to improve our understanding and management of atopic dermatitis with emphasis on chronic skin inflammation and the defense mechanisms of the skin.
Independent school districts Public and state institutions of higher education Private institutions of higher education Federally recognized Native American tribal governments City or township governments Special district governments Public and Indian housing authorities Nonprofits non-higher education with 501(c)(3) Nonprofits non-higher education without 501(c)(3) Other Native American tribal organizations For-profit organizations other than small businesses Refer to Section III.
Eligibility Information in the NOFO for additional information on eligibility. Foreign Organizations/International Collaborations:Non-domestic (non-U.S.) Entities (Foreign Organization) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. Grantor contact information National Institute of Allergy and Infectious Diseases (NIAID) minnicozzim@niaid. nih.
gov minnicozzim@niaid. nih. gov minnicozzim@niaid.
nih. gov File name Description Last updated RFA-AI-27-004-Full-Announcement. html RFA-AI-27-004-Full-Announcement.
html Jun 29, 2026 12:40 PM UTC Link to additional information Closing: September 24, 2026 Funding opportunity number : Cost sharing or matching requirement : Funding instrument type : Opportunity Category Explanation : Category of Funding Activity : Your account requires additional identity verification.
According to the current listing, eligibility includes: Public and state institutions of higher education, private institutions of higher education, federally recognized Native American tribal governments, city or township governments. Confirm the full requirements in the official notice before applying.
The published deadline was September 25, 2026, which has passed. Check the official notice for any future application windows before investing time in a proposal.
Atopic Dermatitis Research Network (ADRN) (U19 Clinical Trial Optional) is funded by National Institutes of Health (NIH). Verify program details on the funder's official page before applying.
Start from the official opportunity page linked in this listing — it carries the sponsor's submission instructions.
PA-27-037 consolidates the Predoctoral to Postdoctoral Transition Award into a single parent announcement across 20 NIH components, with the next deadline December 8, 2026. The eligibility gate is not the science — it is a mandatory change of institution and mentor between the F99 and K00 phases.
Read articleA draft executive order would have put OMB Director Russell Vought on a commission with final say over NIH awards after peer review. Sen. Collins killed it by pointing at a provision Congress already passed. Here is what the episode teaches applicants about the December 11 cliff.
Read articlePA-27-034, PA-27-035 and PA-27-036 replace the institute-specific R25 announcements that research education programs have been built around for a decade. NCI, NIDA and NIGMS have already expired theirs early. Here is what the consolidation actually changes: an 8% indirect cost ceiling, a US-citizens-and-permanent-residents participant rule, a cooperative agreement variant that only exists on one of the three, and no clinical-trial-allowed companion anywhere.
Read article